Anfomed GmbH   Report issue

For profit Phase 4
Founded: Mohrendord Germany (1977)

Organization Overview

First Clinical Trial
2017
NCT03354312
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Anfomed GmbH

Active Ingredients

Drugs in Phase 4 Trials (3)

articaine (Septocaine) (1 trial)

epinephrine (levophed) (1 trial)

lidocaine (xylocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Periodontitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3